Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial

BACKGROUND: Atopic dermatitis is a chronic inflammatory condition with substantial burden and limited treatment options for adolescents with moderate-to-severe disease. Significantly more patients treated with dupilumab vs. placebo achieved Investigator’s Global Assessment 0/1 at week 16. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Paller, Amy S., Bansal, Ashish, Simpson, Eric L., Boguniewicz, Mark, Blauvelt, Andrew, Siegfried, Elaine C., Guttman-Yassky, Emma, Hultsch, Thomas, Chen, Zhen, Mina-Osorio, Paola, Lu, Yufang, Rossi, Ana B., He, Xinyi, Kamal, Mohamed, Graham, Neil M. H., Pirozzi, Gianluca, Ruddy, Marcella, Eckert, Laurent, Gadkari, Abhijit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989562/
https://www.ncbi.nlm.nih.gov/pubmed/31823222
http://dx.doi.org/10.1007/s40257-019-00478-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989562/
https://www.ncbi.nlm.nih.gov/pubmed/31823222
http://dx.doi.org/10.1007/s40257-019-00478-y

Ejemplares similares